Pre-Series A to Series A+ fund research profile
JSW Ventures Fund I is the firm’s inaugural early-stage vehicle, backing Indian technology businesses from pre-Series A to Series A+. The manager’s current portfolio page labels Fund I positions across healthtech, consumer technology and enterprise software. This directory record bundles the manager's related fund series into one family view while retaining vehicle-level terms, portfolios, dates and sources below.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
JSW Ventures uses a pre-series a to series a+; multiple fund vintages bundled approach across Consumer technology, healthtech, enterprise software, fintech.
Current evidence
JSW’s current 2026 platform continues to publish Fund I history, the Fund I portfolio filter and current team and portfolio-company updates.
Bundled fund series
Related manager and vehicle records are shown here as one fund family. The original source trails and vehicle-level caveats remain preserved in the research record.
JSW Ventures Fund I
Vintage / record year: 2016
JSW Ventures Fund II
Vintage / record year: 2020
Strategy
Pre-Series A to Series A+; multiple fund vintages bundled
Sector focus
Consumer technology, healthtech, enterprise software, fintech
AIF structure context
Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.
Current signal
JSW’s current 2026 platform continues to publish Fund I history, the Fund I portfolio filter and current team and portfolio-company updates.
Investor questions
JSW Ventures is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Pre-Series A to Series A+; multiple fund vintages bundled, with a sector focus of Consumer technology, healthtech, enterprise software, fintech. The profile should be read with the linked source trail and Typical route: Category I AIF context.
The profile displays only company or asset names attributable to JSW Ventures in the reviewed public sources: HealthPlix, HomeLane, IndusOS, LimeTray, Overcart, Purplle, Aereo, Convin, Cureskin, EcoSoul, Growcoms, Hyperbots, StayVista, StrideOne, Vetic, Zvolv. It does not represent a complete current portfolio unless the manager has published one.
The manager reports Fund I returning 3x the initial corpus. This is a manager-reported outcome and is not presented as audited IRR, DPI or TVPI. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: $10 million, as reported on the manager’s current fund-history page. Series-level sizing is retained below; aggregate family AUM is not inferred.. Public terms or access information: Early-stage technology venture investing; vehicle-specific cheque sizes, reserves, fees and carry are not publicly disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Sachin Tagra, Vikas Chandak, Gaurav Sachdeva, Niyati Raval, Karan Seth. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Vehicle-level audited returns, fees, carry and full LP terms are not publicly disclosed; the manager’s return figures are presented as firm-reported outcomes. Vehicle-level differences remain identified in the bundled series records..
2026-10-20: JSW’s current 2026 platform continues to publish Fund I history, the Fund I portfolio filter and current team and portfolio-company updates.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.